July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
March 8, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy August 3, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy Tucson, Arizona – August
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 Ju
Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Consortium July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Con
